Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus

Background. Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control may reduce long-term CVD risk. However, other risk factors such as elevated vascular sympathetic tone and/or endothelial dy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamarthi, Bindu, Gaziano, J. Michael, Blonde, Lawrence, Vinik, Aaron, Scranton, Richard E., Ezrokhi, Michael, Rutty, Dean, Cincotta, Anthony H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427775/
https://www.ncbi.nlm.nih.gov/pubmed/26060823
http://dx.doi.org/10.1155/2015/157698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427775/
https://www.ncbi.nlm.nih.gov/pubmed/26060823
http://dx.doi.org/10.1155/2015/157698

Ejemplares similares